Alix Ventures — Full Portfolio
20 tracked investments · listed companies and verified rows first
64x Bio develops cell-line engineering and production technologies to overcome manufacturing bottlenecks in advanced and next-generation therapies.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Lexi Rovner(CEO, Co-founder, Board of Directors)inAlexis Rovner(Founder)Ryan GallagherEmily Hawkins(Head of Talent)George Church, PhD(Co-founder, Scientific Advisory Board)David Thompson, PhD(Co-founder, Scientific Advisory Board)
Co-investorsFifty YearsFuture VenturesG VenturesLifeforce CapitalRaptor GroupY Combinator+8 more
Basil Systems provides a big-data SaaS platform called Basil Intel that consolidates global regulatory, clinical, safety, and commercial data into a single indexed dataset for analytics and insights.
AI & Machine LearningHealthtechSaaSBoston, US
Anthony Cirurgiao(Executive Officer, Director)Luca Fabbri(Director)Bert Amato(Director)
Co-investorsAlumni VenturesService Provider CapitalUntapped CapitalWild Basin InvestmentsGolden VenturesHearst Ventures+1 more
Chemify builds automated chemical synthesis systems combining chemistry, AI, and robotics to digitize molecular design and manufacturing.
AI & Machine LearningBiotechDeep TechGlasgow, GB
Lee Cronin(Founder)inLeroy Cronin(Founder)
Co-investorsBlueYard CapitalInsight PartnersCreator FundEos AdvisoryHAWKTAILHorizons Ventures+12 more
Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.
BiotechDeep TechSan Carlos, US
Matthew Hill(Executive Officer, Director)in
BoardPeter Zhou(Director)inCain McClary(Director)inJonathan Sheena(Director)in
Co-investorsACVC PartnersAndreessen HorowitzIn-Q-TelKdT VenturesRaptor GroupTriatomic Capital+3 more
Endpoint Health develops and commercializes precision therapeutics and therapy-guiding diagnostic tests targeted to each patient's biology, focused on immune-driven critical and chronic illnesses.
BiotechDigital HealthHealthtechSan Francisco, US
Diego Rey(Founder/CSO)inJeff Osborn(Founder)inJason Springs(Founder)inLeonardo Teixeira(Founder)in
Co-investorsGlobal Health Investment CorporationKnockout CapitalY CombinatorAME Cloud VenturesBoom CapitalBoom Capital Ventures+6 more
iOrganBio builds CellForge, an AI- and automation-driven platform for engineering and manufacturing human cells and organoids.
Co-investorsCape Fear BioCapitalFirst Star VenturesHartmann CapitalSOSVIndieBio
Mythic builds analog processing units based on compute-in-memory architecture designed to run AI workloads efficiently in real-world applications.
AI & Machine LearningHardwareSemiconductorsPalo Alto, US
Mike Henry(Founder)inTaner Ozcelik(CEO / Board Member)inSteven Pho(CFO)Dave Fick(Founder)
Co-investorsCatapult VenturesLinse CapitalNew Enterprise Associates (NEA)S3 VenturesAtreides ManagementDCVC (Data Collective)+17 more
Pair Team operates a medical group and is building an AI-based care manager for complex, low-income patients covered by Medicaid, Medicare, and public assistance programs, addressing clinical, behavioral, and social needs such as housing, food, and transportation.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Neil Batlivala(Founder)inCassie Choi(Founder)inCassandra Choi(Executive Officer, Director)inAndres Calabrese(Engineer)Lucas Cook(Software Engineer)Lori Sparks(Recruiting)
Co-investorsAugment VenturesCraft VenturesCREATE HEALTH VENTURESGaingelsHead & Heart CapitalHeadwater Ventures+18 more
Strand is a clinical-stage biotechnology company developing programmable mRNA therapeutics for cancers and autoimmune diseases.
AI & Machine LearningBiotechMedical DevicesBoston, US
Jacob Becraft(CEO, Co-Founder)inTasuku Kitada(President, Head of R&D, Co-founder)inRon Weiss(Scientific Co-founder)inDarrell J. Irvine(Scientific Co-founder)inPrashant Nambiar(Chief Scientific Officer)Ethan Cash(Senior Vice President, Head of Portfolio Management and Program Development)in
Co-investorsAtinum Investment Co. Ltd.FPVLG Technology VenturesPlayground GlobalPotentum PartnersAmgen Ventures+5 more
Teiko provides CLIA-validated high-dimensional cytometry services—including spectral flow and mass cytometry panels, blood preservation kits, gating, and a data analysis dashboard—for immune cell profiling in clinical trials.
BiotechDigital HealthHealthtechSalt Lake City, US
Ramji Srinivasan(Executive Officer, Director)inMatt(Co-founder)inMatthew Spitzer(Director)
BoardVictor Wang(Director)in
Co-investorsCivilization Ventures Management, LlcHAWKTAILHOF CapitalTau VenturesTwine VenturesWestern Technology Investment+2 more
Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities.
AI & Machine LearningBiotechDeep TechSan Diego, US
Martin SmrcinainMaina NdunguinSwamy Vijayan(Executive Officer, Director)inYi ZhanginVikas Goelin
BoardJustin Briggsin
Co-investorsAcequia Capital (AceCap)BlueYard CapitalFoundersX VenturesGlobal BrainHAWKTAILIaso Ventures+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
64xCircularisCloraCytosolixExthymicGalateaSTRMXilis, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.













































__Twitter.png)









.png)














